US FDA Grants Expanded Approval of ELEVIDYS Gene Therapy for DMD Patients Ages 4 and Above

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

The Diagnostic Odyssey in Myasthenia Gravis Patient #4: MuSK MG misdiagnosed as ALS

Activity Snapshot

Activity Type: 
Print/PDF
Release Date: 
Monday, April 11, 2022

Faculty

Ryan Ghusayni, MD
Duke University, Durham, North Carolina
Donal Sanders, MD
Duke University, Durham, North Carolina
Activity Overview: 

This case study will explore MuSK myasthenia gravis (MG) misdiagnosed as ALS in patient #4 (52-year-old-female).

Learning Objectives: 
  • Recognize clinical symptoms indicative of MG
  • Understand the optimal workflow for diagnosis based on clinical evaluation, detection of characteristic symptoms and physical findings, a detailed patient history, and a variety of specialized tests
  • Diagnose MG with increased skill and confidence, shortening the diagnostic journey of patients with MG
  • Understand how to optimize medical management of MG based on best practice guidelines